Remicade (infliximab) is a brand-name intravenous infusion that’s prescribed for certain autoimmune conditions. Remicade has interactions with some other drugs and certain vaccines. Examples ...

The US Food and Drug Administration has approved Celltrion's biosimilar of Johnson & Johnson's Remicade (infliximab) - but the launch date of the blockbuster's cheaper rival remains uncertain.

Remicade (infliximab) is a prescription drug that’s used to treat certain autoimmune conditions, such as rheumatoid arthritis. The drug is given as an intravenous (IV) infusion by a healthcare ...

At 12 months, the rate of IBD-related surgeries for the monitored group was 1% versus 7% for the control group.

The first of these biologics, infliximab (Remicade), became available in 1998. The nine biologics we evaluate are: All of them are very expensive. A new biologic, Xeljanz (tofacitinib), that is ...

Samsung Bioepis said the CHMP opinion was based on phase 1 and phase 3 studies that tested the biosimilarity of Flixabi to Remicade. The CHMP recommended Flizabi in all its EU indications ...

And they’ll recommend the best ways to manage it. Do Inflectra and Remicade have the same side effects? Inflectra and Remicade have similar side effects. This is because Inflectra is a ...

Inflammatory bowel disease is a chronic condition that can cause diarrhea, pain, bleeding, anemia, intestinal blockage, and other serious problems. The two most common types of IBD are Crohn's ...

You may use drugs such as adalimumab (Humira Pen, Humira Pen Crohn's-UC-HS Start, Humira Pen Psoriasis-Uveitis), etanercept (Enbrel), or infliximab (Avsola, Inflectra, Ixifi, Remicade, Renflexis).

Generic/biosimilar competition for drugs like Zytiga and Remicade is likely to have hurt the top line. Overall, Innovative Medicine sales growth is expected to be slightly stronger in the first ...

Approximately two-thirds of patients with Crohn's disease who initially responded to tumor necrosis factor (TNF) inhibitors ...